TY - JOUR
T1 - Blood pressure and its associations in 554 children and young people with congenital adrenal hyperplasia
AU - Lawrence, Neil R.
AU - Bacila, Irina
AU - Tonge, Joseph
AU - Dawson, Jeremy
AU - Collins, Gary S.
AU - Lang, Zi Qiang
AU - Bryce, Jillian
AU - Alimussina, Malika
AU - Chen, Minglu
AU - Ali, Salma Rashid
AU - Adam, Safwaan
AU - Van Den Akker, Erica L.T.
AU - Bachega, Tânia Aparecida Sartori Sanchez
AU - Baronio, Federico
AU - Birkebæk, Niels Holtum
AU - Bonfig, Walter
AU - Claahsen - Van Der Grinten, Hedi
AU - Cools, Martine
AU - Costa, Eduardo Correa
AU - Debono, Miguel
AU - De Vries, Liat
AU - Flück, Christa E.
AU - Gazdagh, Gabriella
AU - Güven, Ayla
AU - Hannema, Sabine E.
AU - Iotova, Violeta
AU - Van Der Kamp, Hetty J.
AU - Krone, Ruth
AU - Leka-Emiri, Sofia
AU - Clemente-León, María
AU - Lichiardopol, Corina Raducanu
AU - Markosyan, Renata L.
AU - Milenkovic, Tatjana
AU - De Miranda, Mirela Costa
AU - Neumann, Uta
AU - Newell-Price, John
AU - Poyrazoǧlu, Şükran
AU - Probst-Scheidegger, Ursina
AU - Russo, Gianni
AU - De Sanctis, Luisa
AU - Seneviratne, Sumudu Nimali
AU - Stancampiano, Marianna Rita
AU - Tadokoro-Cuccaro, Rieko
AU - Thankamony, Ajay
AU - Vieites, Ana
AU - Wasniewska, Malgorzata
AU - Yeste, Diego
AU - Tomlinson, Jeremy
AU - Ahmed, S. Faisal
AU - Krone, Nils
N1 - Publisher Copyright:
© 2025 Oxford University Press. All rights reserved.
PY - 2025/5/1
Y1 - 2025/5/1
N2 - Background: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) affects approximately 1 in 15 000 individuals. We leveraged the power of multicentre registry data to assess the trend and predictors of blood pressure (BP) within children and young persons with 21OHD to inform monitoring strategies. Method: Data from the International CAH Registry in patients younger than 20 years was compared to normative values. Values of BP were modeled to create reference curves, multiple change point analysis applied to quantify the difference with normative data. Covariate adjustment was informed by a directed acyclic graph, prior to joint outcome regression modeling to accurately assess predictors of BP. Results: A total of 6436 visits within 554 patients (52.5% females) showed BP-Standard deviation scores (SDS) were higher at younger ages. Patients under five years had systolic BP-SDS of 1.6 (Q1:0.6-Q3:2.7) decreasing to 1.0 (Q1:0.2-Q3:1.8) over 5 years, equating to 31.0% over the 95th centile decreasing to 15.0%. Higher doses of fludrocortisone were associated with a small increase in systolic BP equivalent to 1.2 mmHg with every 100 g extra fludrocortisone. Renin of 100 U/mL was associated with 4.6 mmHg lower systolic BP than a renin of 1 U/ mL, higher 17OH-progesterone and androstenedione also predicted lower systolic and diastolic BP (P < .05). Conclusion: Higher BP in children with 21OHD is common and particularly pronounced at a younger age, but may not be attributable to excessive mineralocorticoid replacement. There is a need to improve our understanding of the determinants of this raised BP as well as its long-term effects. The Author(s) 2025.
AB - Background: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) affects approximately 1 in 15 000 individuals. We leveraged the power of multicentre registry data to assess the trend and predictors of blood pressure (BP) within children and young persons with 21OHD to inform monitoring strategies. Method: Data from the International CAH Registry in patients younger than 20 years was compared to normative values. Values of BP were modeled to create reference curves, multiple change point analysis applied to quantify the difference with normative data. Covariate adjustment was informed by a directed acyclic graph, prior to joint outcome regression modeling to accurately assess predictors of BP. Results: A total of 6436 visits within 554 patients (52.5% females) showed BP-Standard deviation scores (SDS) were higher at younger ages. Patients under five years had systolic BP-SDS of 1.6 (Q1:0.6-Q3:2.7) decreasing to 1.0 (Q1:0.2-Q3:1.8) over 5 years, equating to 31.0% over the 95th centile decreasing to 15.0%. Higher doses of fludrocortisone were associated with a small increase in systolic BP equivalent to 1.2 mmHg with every 100 g extra fludrocortisone. Renin of 100 U/mL was associated with 4.6 mmHg lower systolic BP than a renin of 1 U/ mL, higher 17OH-progesterone and androstenedione also predicted lower systolic and diastolic BP (P < .05). Conclusion: Higher BP in children with 21OHD is common and particularly pronounced at a younger age, but may not be attributable to excessive mineralocorticoid replacement. There is a need to improve our understanding of the determinants of this raised BP as well as its long-term effects. The Author(s) 2025.
KW - Bayesian analysis
KW - blood pressure
KW - congenital adrenal hyperplasia
KW - glucocorticoids
KW - statistical modeling
UR - https://www.scopus.com/pages/publications/105004757638
U2 - 10.1093/ejendo/lvaf060
DO - 10.1093/ejendo/lvaf060
M3 - Article
C2 - 40184493
AN - SCOPUS:105004757638
SN - 0804-4643
VL - 192
SP - 529
EP - 539
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
IS - 5
ER -